ALGS Aligos Therapeutics, Inc.
Nasdaq · SEC CIK 1799448 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 82 since 2021-11-18, latest 2026-06-29 16:38
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 3
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-27 | 2023-10-25 | ALGS | Scopa James Paul | Dir | A - Grant | $0.76 | +183.1K | 183.1K | New | +$139.1K |
| DI | 2023-10-27 | 2023-10-25 | ALGS | Nuechterlein Carole | Dir, 10% | P - Purchase | $0.76 | +7.93M | 11.03M | +257% | +$6.03M |
| D | 2023-10-27 | 2023-10-25 | ALGS | BLATT LAWRENCE | CEO, Dir | A - Grant | $0.76 | +610.3K | 1.85M | +49% | +$463.8K |
Purchase Sale Sale after option exercise All abbreviations